Recombinant Type III Collagen (RHCS) is designed according to the core high-activity functional sequence of human Type III collagen, featuring high-density triple-helix domains. Often celebrated in the industry as the crucial 'baby collagen', it governs cutaneous suppleness and delicate texture.
Powered by transdermal technology, it smoothly traverses the stratum corneum to reach the basal microenvironment, stimulating fibroblast vitality and replenishing the extracellular matrix. It softens fine dehydration lines, enhances elasticity and bounce, and provides gentle soothing care for compromised or post-sunlight exposed skin.
Cell Activity Data
Fibroblast proliferation and endogenous collagen secretion enhancement experimental data.
RAW MATERIAL TECHNICAL & REGULATORY DOSSIER
Comprehensive Technical, Quality Specification, and Regulatory Dossier for R&D Formulators, Procurement, and Product Managers
📊
Biotechnology Mechanism & Scientific Evidence
Authoritative Brochure Technical Diagram · Molecular Model · Transdermal & Efficacy Mechanism
Mechanism DiagramRecombinant Type III humanized collagen triple-helix spatial conformation and integrin binding sites.
🔬
Formulation R&D Engineer Guide (R&D Technical Dossier)
Formulation Application · Physicochemical Parameters · Stability & Compatibility
| INCI Name (CN) |
Soluble Collagen, EDTA two 钠、1,2-1,2-Hexanediol, Aqua |
INCI Name (EN) |
Soluble Collagen, Disodium EDTA, 1,2-Hexanediol, Aqua |
| CAS No. |
9007-34-5 / 139-33-3 / 6920-22-5 / 7732-18-5 |
Recommended Dosage |
0.3% - 3.0%（Anti-Wrinkle 0.5% - 1.5%） |
| Optimal pH Range |
5.5 - 6.8 |
Thermal Processing |
Add below 40°C during cooling phase |
| Appearance & Odor |
Colorless transparent liquid, clear and odorless |
Solubility & Method |
Easily miscible with water in all proportions |
💡 Compatibility Guidelines & Precautions: Compatible with standard formulation bases, peptides, and polyols
📦
Procurement & Compliance Dossier (Procurement & Compliance)
NMPA Code · MOQ · Sampling Support · Certificate of Analysis
| NMPA Submission Code |
✓ 132220-00075-4002 |
Supply Packaging |
1kg/fluorinated bottle, 5kg/drum, 25kg/drum |
| Minimum Order Quantity (MOQ) |
1 kg (Ready Stock) |
Delivery Lead Time |
Dispatched within 24-48 hours |
| Storage Conditions |
Store refrigerated at 2-8°C, protected from light |
Shelf Life (Shelf Life) |
24 Months |
| R&D Sample Support |
Complimentary 50g trial sample available |
Quality Documentation |
Batch COA, SDS, TDS, SEC-HPLC Purity & Endotoxin Reports |
💡
Product Planning & Marketing Highlights (Marketing Highlights)
Core Mechanism · Efficacy Claims · Recommended Formats · Scientific Backing
🧬 Core Bio-Tech Barrier & Mechanism of Action:
Engineered with the human Type III collagen core functional sequence, accelerating fibroblast proliferation and binding discoidin domain receptors (DDRs) to replenish baby-like skin suppleness.
✨ Key Selling Point Keywords:
🏷️ High-Homology Recombinant Type III Collagen🏷️ Deep Plumping & Elastic Bounciness🏷️ Smoothing Fine Lines & Expression Wrinkles🏷️ Promoting Collagen Replenishment🏷️ Gentle & Bio-Absorbable
🧴 Recommended Product Formats & Categories:
Anti-aging collagen serums, firming bounce creams, hydrogel face masks, clinic-grade aesthetic post-care
📜 Patented Technologies & Scientific Backing:
Granted Chinese Invention Patent on High-Density Yeast-Expressed Recombinant Collagen
⚖️
Regulatory Compliance & Peer-to-Peer Disclaimer
Regulatory & Professional Compliance Statement:
1. The raw material characteristics and experimental data (including cytological studies, mechanism diagrams, and literature citations) presented on this webpage are intended exclusively for technical discussion and formulation R&D reference by cosmetic brand formulators, R&D engineers, product planners, and academic research institutions. They do not constitute finished consumer cosmetic efficacy claims or commercial warranties.
2. Pursuant to the Regulations on the Supervision and Administration of Cosmetics, Standards for Cosmetic Efficacy Claim Evaluation, and relevant global cosmetic regulatory frameworks, cosmetic brand enterprises utilizing this raw material shall be solely responsible for the safety, stability, and efficacy claims of their finished consumer products, and shall independently complete efficacy evaluations and regulatory filings/registrations with the competent health authorities prior to commercial launch. Conclusions from in-vitro or cellular studies shall not be directly extrapolated as consumer claims.
3. Mellgen Biotech assumes no joint or indirect liability for any claims or regulatory non-compliance arising from improper customer formulation, unauthorized off-label claims, or unverified applications.
